Expansion Opportunities The Eye Institute of Utah demonstrates ongoing adoption of advanced ophthalmic technologies and innovations (Epioxa corneal cross-linking, Valeda therapy for dry AMD, Visian Toric ICL in the past) indicating a readiness to partner with vendors or service providers that support cutting-edge treatments and clinical workflows. Use this to position capabilities in equipment partnerships, device financing, training programs, and clinical trial collaboration.

Tech Adoption With a tech stack featuring The Trade Desk, WordPress, PHP, and modern web practices, the organization values digital tools for outreach and patient engagement. This suggests opportunities in healthcare marketing tech, patient acquisition platforms, telemedicine integration, and secure patient communication solutions that align with their existing digital footprint.

Growth Readiness Revenue visibility in the multi‑million range and a history of introducing high‑end procedures imply capacity for scale and new service lines. This creates potential sales avenues for equipment upgrades, service contracts, training for staff on new procedures, and financing options to expand surgical capabilities or multi‑site operations.

Clinical Leadership The organization emphasizes experienced specialists and research leadership in ophthalmology, signaling openness to partnerships in clinical research, accreditations, continuous medical education programs, and collaborative studies with device manufacturers or pharma partners.

Regional Footprint Positioned as a leading eye care center in the Intermountain West with a 35-year track record, The Eye Institute of Utah is well-placed to target regional payers, hospital networks, and expanded referral partnerships. Focus on scalable solutions, referral management, and enterprise health IT integrations to support growth and interoperability.